Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

EGFR amplification status for clinical trial inclusion: Where do we draw the line?

Molinaro AM, Phillips JJ.

Neuro Oncol. 2019 Aug 28. pii: noz146. doi: 10.1093/neuonc/noz146. [Epub ahead of print] No abstract available.

PMID:
31504815
2.

A historical cohort of temporal lobe surgery for medically refractory epilepsy: a systematic review and meta-analysis to guide future nonrandomized controlled trial studies.

Lee AT, Burke JF, Chunduru P, Molinaro AM, Knowlton R, Chang EF.

J Neurosurg. 2019 Jun 28:1-8. doi: 10.3171/2019.4.JNS183235. [Epub ahead of print]

PMID:
31252393
3.

Residual Tumor Volume and Location Predict Progression After Primary Subtotal Resection of Sporadic Vestibular Schwannomas: A Retrospective Volumetric Study.

Breshears JD, Morshed RA, Molinaro AM, McDermott MW, Cheung SW, Theodosopoulos PV.

Neurosurgery. 2019 Jun 24. pii: nyz200. doi: 10.1093/neuros/nyz200. [Epub ahead of print]

PMID:
31232426
4.

Genetic and molecular epidemiology of adult diffuse glioma.

Molinaro AM, Taylor JW, Wiencke JK, Wrensch MR.

Nat Rev Neurol. 2019 Jul;15(7):405-417. doi: 10.1038/s41582-019-0220-2. Epub 2019 Jun 21. Review.

PMID:
31227792
5.

Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk.

Muskens IS, Hansen HM, Smirnov IV, Molinaro AM, Bondy ML, Schildkraut JM, Wrensch M, Wiemels JL, Claus EB.

J Neurooncol. 2019 May;142(3):479-487. doi: 10.1007/s11060-019-03119-w. Epub 2019 Feb 22.

PMID:
30796745
6.

Safety of Outpatient Anterior Cervical Discectomy and Fusion: A Systematic Review and Meta-Analysis.

Yerneni K, Burke JF, Chunduru P, Molinaro AM, Riew KD, Traynelis VC, Tan LA.

Neurosurgery. 2019 Jan 23. doi: 10.1093/neuros/nyy636. [Epub ahead of print]

PMID:
30690479
7.

Risk factors of radiotherapy-induced cerebral microbleeds and serial analysis of their size compared with white matter changes: A 7T MRI study in 113 adult patients with brain tumors.

Morrison MA, Hess CP, Clarke JL, Butowski N, Chang SM, Molinaro AM, Lupo JM.

J Magn Reson Imaging. 2019 Sep;50(3):868-877. doi: 10.1002/jmri.26651. Epub 2019 Jan 20.

PMID:
30663150
8.

Using germline variants to estimate glioma and subtype risks.

Eckel-Passow JE, Decker PA, Kosel ML, Kollmeyer TM, Molinaro AM, Rice T, Caron AA, Drucker KL, Praska CE, Pekmezci M, Hansen HM, McCoy LS, Bracci PM, Erickson BJ, Lucchinetti CF, Wiemels JL, Wiencke JK, Bondy ML, Melin B, Burns TC, Giannini C, Lachance DH, Wrensch MR, Jenkins RB.

Neuro Oncol. 2019 Mar 18;21(4):451-461. doi: 10.1093/neuonc/noz009.

PMID:
30624711
9.

Impact of pretreatment growth on Tumor control for vestibular schwannomas following gamma knife.

Chang J, Breshears JD, Molinaro AM, Sneed PK, McDermott MW, Theodosopoulos PV, Tward AD.

Laryngoscope. 2019 Mar;129(3):743-747. doi: 10.1002/lary.27427. Epub 2018 Nov 8.

PMID:
30408172
10.

SoxB1 Activity Regulates Sensory Neuron Regeneration, Maintenance, and Function in Planarians.

Ross KG, Molinaro AM, Romero C, Dockter B, Cable KL, Gonzalez K, Zhang S, Collins ES, Pearson BJ, Zayas RM.

Dev Cell. 2018 Nov 5;47(3):331-347.e5. doi: 10.1016/j.devcel.2018.10.014.

PMID:
30399335
11.

Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.

Taylor JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA, Clarke JL, Oberheim-Bush NA, Chang SM, Berger MS, Prados M.

J Neurooncol. 2018 Nov;140(2):477-483. doi: 10.1007/s11060-018-2977-3. Epub 2018 Aug 27.

PMID:
30151703
12.

Comparative transcriptomic analyses and single-cell RNA sequencing of the freshwater planarian Schmidtea mediterranea identify major cell types and pathway conservation.

Swapna LS, Molinaro AM, Lindsay-Mosher N, Pearson BJ, Parkinson J.

Genome Biol. 2018 Aug 24;19(1):124. doi: 10.1186/s13059-018-1498-x.

13.

Myths vs. FACS: what do we know about planarian stem cell lineages?

Molinaro AM, Pearson BJ.

Int J Dev Biol. 2018;62(6-7-8):527-535. doi: 10.1387/ijdb.180066bp. Review.

14.

Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas.

Luks TL, McKnight TR, Jalbert LE, Williams A, Neill E, Lobo KA, Persson AI, Perry A, Phillips JJ, Molinaro AM, Chang SM, Nelson SJ.

Transl Oncol. 2018 Aug;11(4):941-949. doi: 10.1016/j.tranon.2018.05.005. Epub 2018 Jun 18.

15.

Disparities in health care determine prognosis in newly diagnosed glioblastoma.

Chandra A, Rick JW, Dalle Ore C, Lau D, Nguyen AT, Carrera D, Bonte A, Molinaro AM, Theodosopoulos PV, McDermott MW, Berger MS, Aghi MK.

Neurosurg Focus. 2018 Jun;44(6):E16. doi: 10.3171/2018.3.FOCUS1852.

16.

Temporal Dynamics of Pseudoprogression After Gamma Knife Radiosurgery for Vestibular Schwannomas-A Retrospective Volumetric Study.

Breshears JD, Chang J, Molinaro AM, Sneed PK, McDermott MW, Tward A, Theodosopoulos PV.

Neurosurgery. 2019 Jan 1;84(1):123-131. doi: 10.1093/neuros/nyy019.

PMID:
29518221
17.

Postoperative Delirium in Glioblastoma Patients: Risk Factors and Prognostic Implications.

Flanigan PM, Jahangiri A, Weinstein D, Dayani F, Chandra A, Kanungo I, Choi S, Sankaran S, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2018 Dec 1;83(6):1161-1172. doi: 10.1093/neuros/nyx606.

PMID:
29462362
18.

The planarian TCF/LEF factor Smed-tcf1 is required for the regeneration of dorsal-lateral neuronal subtypes.

Brown DDR, Molinaro AM, Pearson BJ.

Dev Biol. 2018 Jan 15;433(2):374-383. doi: 10.1016/j.ydbio.2017.08.024. Epub 2017 Dec 25.

19.

Clinical trial endpoints for patients with gliomas.

Taylor JW, Molinaro AM, Butowski N, Prados M.

Neurooncol Pract. 2017 Dec;4(4):201-208. doi: 10.1093/nop/npw034. Epub 2017 Feb 14. Review.

20.

FOX and ETS family transcription factors regulate the pigment cell lineage in planarians.

He X, Lindsay-Mosher N, Li Y, Molinaro AM, Pellettieri J, Pearson BJ.

Development. 2017 Dec 15;144(24):4540-4551. doi: 10.1242/dev.156349. Epub 2017 Nov 20.

21.

Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma.

Byron SA, Tran NL, Halperin RF, Phillips JJ, Kuhn JG, de Groot JF, Colman H, Ligon KL, Wen PY, Cloughesy TF, Mellinghoff IK, Butowski NA, Taylor JW, Clarke JL, Chang SM, Berger MS, Molinaro AM, Maggiora GM, Peng S, Nasser S, Liang WS, Trent JM, Berens ME, Carpten JD, Craig DW, Prados MD.

Clin Cancer Res. 2018 Jan 15;24(2):295-305. doi: 10.1158/1078-0432.CCR-17-0963. Epub 2017 Oct 26.

22.

Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.

Jacobs DI, Liu Y, Gabrusiewicz K, Tsavachidis S, Armstrong GN, Zhou R, Wei J, Ivan C, Calin G, Molinaro AM, Rice T, Bracci PM, Hansen HM, Wiencke JK, Wrensch MR, Heimberger AB, Bondy ML.

J Neurooncol. 2018 Jan;136(1):33-39. doi: 10.1007/s11060-017-2622-6. Epub 2017 Sep 30.

23.

Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor.

Autry A, Phillips JJ, Maleschlijski S, Roy R, Molinaro AM, Chang SM, Cha S, Lupo JM, Nelson SJ.

Transl Oncol. 2017 Dec;10(6):895-903. doi: 10.1016/j.tranon.2017.08.009. Epub 2017 Sep 22.

24.

Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1.

Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, Cairncross JG, Perry A, Nelson SJ, Chang SM, Bollen AW, Molinaro AM, Bengtsson H, Olshen AB, Weiss S, Phillips JJ, Luchman HA, Costello JF.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10743-10748. doi: 10.1073/pnas.1708914114. Epub 2017 Sep 15.

25.

Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.

Wahl M, Chang SM, Phillips JJ, Molinaro AM, Costello JF, Mazor T, Alexandrescu S, Lupo JM, Nelson SJ, Berger M, Prados M, Taylor JW, Butowski N, Clarke JL, Haas-Kogan D.

Cancer. 2017 Dec 1;123(23):4631-4639. doi: 10.1002/cncr.30909. Epub 2017 Jul 31.

26.

Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI.

Anwar M, Molinaro AM, Morin O, Chang SM, Haas-Kogan DA, Nelson SJ, Lupo JM.

Radiat Res. 2017 Sep;188(3):303-313. doi: 10.1667/RR14662.1. Epub 2017 Jul 19.

27.

Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.

Flanigan PM, Jahangiri A, Kuang R, Truong A, Choi S, Chou A, Rick JW, Chang SM, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2017 Nov 1;81(5):824-833. doi: 10.1093/neuros/nyx084.

28.

Developing an Algorithm for Optimizing Care of Elderly Patients With Glioblastoma.

Flanigan PM, Jahangiri A, Kuang R, Truong A, Choi S, Chou A, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2018 Jan 1;82(1):64-75. doi: 10.1093/neuros/nyx148.

PMID:
28475720
29.

Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma.

Jalbert LE, Elkhaled A, Phillips JJ, Neill E, Williams A, Crane JC, Olson MP, Molinaro AM, Berger MS, Kurhanewicz J, Ronen SM, Chang SM, Nelson SJ.

Sci Rep. 2017 Mar 22;7:44792. doi: 10.1038/srep44792.

30.

Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.

Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, Bracci PM, Eckel-Passow JE, Lachance DH, Clarke J, Taylor JW, Luks T, Wiencke JK, Jenkins RB, Wrensch MR.

Acta Neuropathol. 2017 Jun;133(6):1001-1016. doi: 10.1007/s00401-017-1690-1. Epub 2017 Mar 2.

31.

Phase I cancer clinical trials.

Cabrera JR, Taylor JW, Molinaro AM.

Neurooncol Pract. 2017 Mar;4(1):67-72. doi: 10.1093/nop/npw014. Epub 2016 Aug 26. Review.

32.

A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma.

Clarke JL, Molinaro AM, Cabrera JR, DeSilva AA, Rabbitt JE, Prey J, Drummond DC, Kim J, Noble C, Fitzgerald JB, Chang SM, Butowski NA, Taylor JW, Park JW, Prados MD.

Cancer Chemother Pharmacol. 2017 Mar;79(3):603-610. doi: 10.1007/s00280-017-3247-3. Epub 2017 Feb 23.

PMID:
28233053
33.

Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival.

Wiencke JK, Koestler DC, Salas LA, Wiemels JL, Roy RP, Hansen HM, Rice T, McCoy LS, Bracci PM, Molinaro AM, Kelsey KT, Wrensch MR, Christensen BC.

Clin Epigenetics. 2017 Feb 2;9:10. doi: 10.1186/s13148-017-0316-8. eCollection 2017.

34.

Body mass index, height and early-onset basal cell carcinoma in a case-control study.

Zhang Y, Cartmel B, Choy CC, Molinaro AM, Leffell DJ, Bale AE, Mayne ST, Ferrucci LM.

Cancer Epidemiol. 2017 Feb;46:66-72. doi: 10.1016/j.canep.2016.12.007. Epub 2016 Dec 28.

35.

Neuronal sources of hedgehog modulate neurogenesis in the adult planarian brain.

Currie KW, Molinaro AM, Pearson BJ.

Elife. 2016 Nov 19;5. pii: e19735. doi: 10.7554/eLife.19735.

36.

GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity.

Lindberg OR, McKinney A, Engler JR, Koshkakaryan G, Gong H, Robinson AE, Ewald AJ, Huillard E, David James C, Molinaro AM, Shieh JT, Phillips JJ.

Oncotarget. 2016 Nov 29;7(48):79101-79116. doi: 10.18632/oncotarget.12600.

37.

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.

Han SJ, Reis G, Kohanbash G, Shrivastav S, Magill ST, Molinaro AM, McDermott MW, Theodosopoulos PV, Aghi MK, Berger MS, Butowski NA, Barani I, Phillips JJ, Perry A, Okada H.

J Neurooncol. 2016 Dec;130(3):543-552. Epub 2016 Sep 13.

38.

Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.

Wahl M, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan DA, Costello JF, Dayal M, Butowski N, Clarke JL, Prados M, Nelson S, Berger MS, Chang SM.

Neuro Oncol. 2017 Feb 1;19(2):242-251. doi: 10.1093/neuonc/now176.

39.

Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors.

Roddy E, Sear K, Felton E, Tamrazi B, Gauvain K, Torkildson J, Buono BD, Samuel D, Haas-Kogan DA, Chen J, Goldsby RE, Banerjee A, Lupo JM, Molinaro AM, Fullerton HJ, Mueller S.

Neuro Oncol. 2016 Nov;18(11):1548-1558. Epub 2016 Aug 18.

40.

Comparative Sensitivity of Intraoperative Motor Evoked Potential Monitoring in Predicting Postoperative Neurologic Deficits: Nondegenerative versus Degenerative Myelopathy.

Clark AJ, Safaee M, Chou D, Weinstein PR, Molinaro AM, Clark JP 3rd, Mummaneni PV.

Global Spine J. 2016 Aug;6(5):452-8. doi: 10.1055/s-0035-1565258. Epub 2015 Oct 25.

41.

Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience.

Imber BS, Kanungo I, Braunstein S, Barani IJ, Fogh SE, Nakamura JL, Berger MS, Chang EF, Molinaro AM, Cabrera JR, McDermott MW, Sneed PK, Aghi MK.

Neurosurgery. 2017 Jan 1;80(1):129-139. doi: 10.1227/NEU.0000000000001344.

42.

In silico lineage tracing through single cell transcriptomics identifies a neural stem cell population in planarians.

Molinaro AM, Pearson BJ.

Genome Biol. 2016 Apr 27;17:87. doi: 10.1186/s13059-016-0937-9.

43.

Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy.

Molinaro AM, Sison JD, Ljung BM, Tlsty TD, Kerlikowske K.

Breast Cancer Res Treat. 2016 Jun;157(2):351-361. doi: 10.1007/s10549-016-3814-z. Epub 2016 May 4.

PMID:
27146587
44.

Doubly robust survival trees.

Steingrimsson JA, Diao L, Molinaro AM, Strawderman RL.

Stat Med. 2016 Sep 10;35(20):3595-612. doi: 10.1002/sim.6949. Epub 2016 Mar 31.

PMID:
27037609
45.

Understanding inherited genetic risk of adult glioma - a review.

Rice T, Lachance DH, Molinaro AM, Eckel-Passow JE, Walsh KM, Barnholtz-Sloan J, Ostrom QT, Francis SS, Wiemels J, Jenkins RB, Wiencke JK, Wrensch MR.

Neurooncol Pract. 2016 Mar;3(1):10-16. Epub 2015 Aug 25.

46.

Magnetic resonance analysis of malignant transformation in recurrent glioma.

Jalbert LE, Neill E, Phillips JJ, Lupo JM, Olson MP, Molinaro AM, Berger MS, Chang SM, Nelson SJ.

Neuro Oncol. 2016 Aug;18(8):1169-79. doi: 10.1093/neuonc/now008. Epub 2016 Feb 23.

47.

Stereotactic probability and variability of speech arrest and anomia sites during stimulation mapping of the language dominant hemisphere.

Chang EF, Breshears JD, Raygor KP, Lau D, Molinaro AM, Berger MS.

J Neurosurg. 2017 Jan;126(1):114-121. doi: 10.3171/2015.10.JNS151087. Epub 2016 Feb 19.

PMID:
26894457
48.

PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells.

Mukherjee J, Ohba S, See WL, Phillips JJ, Molinaro AM, Pieper RO.

Int J Cancer. 2016 Jul 1;139(1):99-111. doi: 10.1002/ijc.30041. Epub 2016 Mar 2.

49.

Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials.

Wen Q, Jalilian L, Lupo JM, Li Y, Roy R, Molinaro AM, Chang SM, Prados M, Butowski N, Clarke J, Nelson SJ.

Transl Oncol. 2015 Dec;8(6):446-55. doi: 10.1016/j.tranon.2015.10.001.

50.

Statistical considerations on prognostic models for glioma.

Molinaro AM, Wrensch MR, Jenkins RB, Eckel-Passow JE.

Neuro Oncol. 2016 May;18(5):609-23. doi: 10.1093/neuonc/nov255. Epub 2015 Dec 8. Review.

Supplemental Content

Loading ...
Support Center